The Latest Breaking News from Vaccine

This year was one of the deadliest flu seasons for children in more than 20 years

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.

Family of Tae Heung ‘Will’ Kim, believes detention may be result of South Korean man’s decade-old marijuana misdemeanor

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

Seventeen experts ousted from a U.S. vaccine committee are expressing little faith in what the panel has become

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions